First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated. (Q46090169)
Jump to navigation
Jump to search
scientific article published on 14 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated. |
scientific article published on 14 November 2017 |
Statements
First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated (English)
Sam Jackson
Albert F Candia
Stephen Delaney
Simone Floettmann
Clifford Wong
John D Campbell
Sariah Kell
Jeremy Lum
Paula Traquina
Mark McHale
Ian Robinson
John Bell
Rainard Fuhr
David Keeling
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference